PROM1 and neoplasm: Here, we demonstrate effective in vitro growth inhibition using an anti-CD133 ADC in CD133-expressing hepatocellular carcinoma (Hep3B) and gastric carcinoma (KATO III) cell lines and significant delay of tumour growth in vivo for Hep3B xenograft tumours in SCID mice.